Innovative medical technology advances with first patient enrollments

Vancouver, kelowna, and delta, british columbia--(newsfile corp. - november 12, 2024) - investorideas.com, a go-to investing platform, releases an industry snapshot looking at the future of medical technology as first patients are enrolled in potential breakthrough trials, featuring aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. read the full article on investorideas.com https://www.investorideas.com/news/2024/biotech/11120aemd-first-patient-enrollments.asp according to statista.com, "the medical technology market, which encompasses various markets, including medical devices, is anticipated to witness significant revenue growth in the coming years.
AEMD Ratings Summary
AEMD Quant Ranking